Alfresa Holdings Corporation (2784)

Market cap
¥475.4B
P/E ratio
12.6x
Alfresa Holdings distributes prescription drugs, medical devices, and healthcare products to serve Japan's medical industry through specialized subsidiaries.
Period EndPretax margin (%) YoY (%)
Mar 31, 20251.4-2.29%
Mar 31, 20241.4+14.90%
Mar 31, 20231.2-3.35%
Mar 31, 20221.3+2.75%
Mar 31, 20211.2-42.13%
Mar 31, 20202.1+1.48%
Mar 31, 20192.1+4.78%
Mar 31, 20182+16.54%
Mar 31, 20171.7-20.62%
Mar 31, 20162.2+33.76%
Mar 31, 20151.6-9.50%
Mar 31, 20141.8+31.60%
Mar 31, 20131.4+72.14%
Mar 31, 20120.8
AI Chat